Research on the experimental drug petrelintide suggests it is much less likely to cause nausea and vomiting than GLP-1 drugs, ...
A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide ...
More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, ...
By Nancy Lapid June 3 (Reuters) - A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than ...